MarketPeel
Insider Trading Intelligence
RL

Redmile Group, Llc

FATE
DIRECTOR · FATE THERAPEUTICS INC · CIK 0001425738
FILING MIX · LIFETIME71%/29%
BUYS
103
SELLS
42
TOTAL VALUE
$542.24M
COMPANIES
12
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
39,758,360
AVG SELL PX
$4.17
TRADE KIND
SHOWING 145 / 145
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
59 backtested trades · 8 horizons · 29 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Redmile Group, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d59+61.02%+5.36%+0.44%+4.92%+2.70%2.50
14d59+57.63%+14.17%+0.93%+13.24%+8.18%4.05
30d59+64.41%+30.39%+3.43%+26.95%+9.46%4.53
60d59+66.10%+29.96%+5.12%+29.32%+14.44%3.80
90d59+69.49%+29.97%+5.90%+24.07%+3.15%2.48
180d59(6 pending)+58.49%+16.71%+11.36%+5.35%-11.60%0.73
1y59(7 pending)+34.62%-10.87%+21.94%-32.81%-41.87%-4.18
2y59(16 pending)+53.49%-11.36%+32.60%-43.96%-43.42%-4.82
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FATE · 87,900 shares · as of Jun 12, 2026
03,295,0976,590,1949,885,29113,180,388202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 103 buys / 42 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
87,90087,900Jun 12, 2026Jun 15, 2026View →
FATE
FATE THERAPEUTICS INC
PURCHASE
3,691,3243,893,674Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
PURCHASE
8,977,62412,884,277Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
SALE
162,0130Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
SALE
8,977,6240Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
PURCHASE
162,0132,755,086Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
SALE
3,691,3240Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
SALE
266,2800Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
SALE
266,2800Apr 20, 2026Apr 23, 2026View →
FATE
FATE THERAPEUTICS INC
PURCHASE
266,280502,769Apr 20, 2026Apr 22, 2026View →
FATE
FATE THERAPEUTICS INC
PURCHASE
266,280502,769Apr 20, 2026Apr 23, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
2,529,491$3.28$8.29M10,265,297Apr 2, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
2,634,506$3.28$8.64M12,666,731Apr 2, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
169,265$3.80$643.0K15,301,237Apr 1, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
162,517$3.80$617.4K12,794,788Apr 1, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
196,229$3.75$736.3K15,470,502Mar 31, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
SALE
188,407$3.75$706.9K12,957,305Mar 31, 2026Apr 2, 2026View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
3,846,153$3.90$15.00M3,846,153Oct 27, 2025Oct 28, 2025View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
3,846,153$3.90$15.00M3,846,153Oct 27, 2025Oct 28, 2025View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
4,097,7307,198,553Aug 25, 2025Aug 26, 2025View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
4,097,7304,097,730Aug 25, 2025Aug 26, 2025View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
33,15033,150Jul 14, 2025Jul 16, 2025View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
12,465,234$3.43$42.78M12,465,234Jun 11, 2025Jun 13, 2025View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
15,734,267$3.43$54.00M15,734,267Jun 11, 2025Jun 13, 2025View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
55,00055,000May 29, 2025May 30, 2025View →
FATE
FATE THERAPEUTICS INC
SALE
116,261$8.40$976.6K2,638,825Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASE
116,261$8.40$976.6K2,755,086Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
56,331$1.68$94.6K502,769Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASE
397,964$1.68$668.6K12,884,277Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASE
1,084,936$1.68$1.82M12,827,946Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
341,633$1.68$573.9K12,486,313Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
1,084,936$1.68$1.82M11,743,010Dec 20, 2024Dec 26, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
6,0222,755,086Dec 12, 2024Dec 16, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASE
30,11012,827,946Dec 12, 2024Dec 16, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$3.81$190.5K13,145,712Dec 11, 2024Dec 13, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$2.28$114.0K15,616,731Dec 11, 2024Dec 13, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$3.81$190.5K15,666,731Dec 11, 2024Dec 13, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,000$2.28$114.0K13,095,712Dec 11, 2024Dec 13, 2024View →
STTK
SHATTUCK LABS, INC.
SALE
133,371$1.25$166.7K5,406,353Dec 4, 2024Dec 6, 2024View →
STTK
SHATTUCK LABS, INC.
SALE
1,026,888$1.25$1.28M4,512,836Dec 4, 2024Dec 6, 2024View →
STTK
SHATTUCK LABS, INC.
PURCHASE
1,026,888$1.25$1.28M5,539,724Dec 4, 2024Dec 6, 2024View →
STTK
SHATTUCK LABS, INC.
PURCHASE
133,371$1.25$166.7K5,539,724Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
SALE
50,672$2.07$104.9K15,516,059Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,672$2.07$104.9K15,566,731Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
SALE
26,656$2.07$55.2K8,136,609Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
26,656$2.07$55.2K6,133,837Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
26,656$2.07$55.2K8,163,265Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,672$2.07$104.9K13,045,712Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
SALE
25,352$2.07$52.5K15,566,731Dec 4, 2024Dec 6, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
400,000$2.81$1.12M15,669,217Jul 1, 2024Jul 3, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
400,000$2.81$1.12M12,995,040Jul 1, 2024Jul 3, 2024View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
27,70027,700Jun 21, 2024Jun 21, 2024View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
36,27436,274Jun 12, 2024Jun 14, 2024View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
8,8208,262,136Jun 12, 2024Jun 14, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jun 7, 2024Jun 11, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
6,107,181$4.81$29.39M6,107,181May 8, 2024May 10, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
8,163,265$4.81$39.28M8,163,265May 8, 2024May 10, 2024View →
STTK
SHATTUCK LABS, INC.
SALE
4,4255,615,489Mar 28, 2024Apr 1, 2024View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
3,636,364$5.50$20.00M3,893,674Mar 21, 2024Mar 25, 2024View →
ABSI
ABSCI CORP
PURCHASE
222,222$4.50$1000.0K8,253,316Mar 1, 2024Mar 5, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
107,590107,590Feb 7, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
11,15911,159Feb 2, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
144,517144,517Feb 2, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
SALE
19,700$3.38$66.7K1,180,136Feb 1, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
205,483205,483Feb 1, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
15,86715,867Feb 1, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
150,000150,000Jan 31, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 30, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
150,000150,000Jan 29, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 26, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 25, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,00050,000Jan 24, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
53,90053,900Jan 16, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
93,42493,424Jan 12, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 11, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 10, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 9, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
100,000100,000Jan 8, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
50,00050,000Jan 5, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
28,65228,652Jan 4, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
PURCHASE
56,90056,900Jan 3, 2024Feb 9, 2024View →
ADCT
ADC THERAPEUTICS SA
SALE
59,986$1.68$100.5K1,199,836Jan 3, 2024Feb 9, 2024View →
FATE
FATE THERAPEUTICS INC
SALE
1,655,370$3.72$6.16M13,135,758Dec 26, 2023Dec 28, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
1,655,370$3.72$6.16M13,135,758Dec 26, 2023Dec 28, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
44,630$3.72$166.0K13,180,388Dec 26, 2023Dec 28, 2023View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
3,100,8233,100,823Dec 21, 2023Dec 26, 2023View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
53,10053,100Jun 14, 2023Jun 16, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jun 6, 2023Jun 8, 2023View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
40,25840,258May 26, 2023May 31, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
256,639$6.18$1.59M13,135,758Apr 21, 2023Apr 21, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
20,000$5.99$119.8K12,879,119Apr 20, 2023Apr 21, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
45,752$29.20$1.34M2,761,108Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
54,960$5.84$320.9K257,310Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
5,492,385$5.84$32.08M12,833,419Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
45,752$29.20$1.34M2,761,108Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
25,700$6.00$154.2K12,859,119Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
5,492,385$5.84$32.08M12,833,419Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
54,960$5.84$320.9K257,310Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
302,339$5.84$1.77M12,833,419Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
550,000$5.84$3.21M559,100Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
550,000$5.84$3.21M559,100Apr 14, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
SALE
33,4412,761,108Apr 13, 2023Apr 17, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASE
167,20513,135,758Apr 13, 2023Apr 17, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASEGRANT
Stock grant
30,481$5.03$153.4K6,075,918Oct 13, 2022Oct 17, 2022View →
ZYME
ZYMEWORKS INC.
PURCHASE
30,481$5.03$153.4K6,075,918Oct 13, 2022Oct 18, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
11,89311,893Jun 9, 2022Jun 13, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,65012,968,553Jun 9, 2022Jun 13, 2022View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
40,25840,258Jun 8, 2022Jun 10, 2022View →
ABSI
ABSCI CORP
PURCHASEGRANT
Stock grant
28,70028,700Jun 8, 2022Jun 10, 2022View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
954,4200Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
1,000,000$20.00$20.00M1,954,420Nov 2, 2021Nov 4, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
954,420954,420Nov 2, 2021Nov 4, 2021View →
ABSI
ABSCI CORP
PURCHASE
4,209,5734,209,573Jul 26, 2021Jul 28, 2021View →
ABSI
ABSCI CORP
SALE
4,209,5730Jul 26, 2021Jul 28, 2021View →
ABSI
ABSCI CORP
SALE
0Jul 26, 2021Jul 28, 2021View →
ABSI
ABSCI CORP
PURCHASE
1,946,5216,156,094Jul 26, 2021Jul 28, 2021View →
ABSI
ABSCI CORP
PURCHASE
1,875,000$16.00$30.00M8,031,094Jul 26, 2021Jul 28, 2021View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
3,4343,434Jun 19, 2021Jun 22, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
2,68112,959,903Jun 2, 2021Jun 4, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
4,3344,334Jun 2, 2021Jun 4, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASE
257,310$85.50$22.00M257,310Jan 8, 2021Jan 12, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASE
327,485$85.50$28.00M12,957,222Jan 8, 2021Jan 12, 2021View →
APRE
APREA THERAPEUTICS, INC.
SALE
494,137$5.58$2.76M1,774,581Dec 28, 2020Feb 16, 2021View →
APRE
APREA THERAPEUTICS, INC.
SALE
5,863$5.80$34.0K1,768,718Dec 28, 2020Feb 16, 2021View →
STTK
SHATTUCK LABS, INC.
PURCHASEGRANT
Stock grant
1,2861,286Dec 22, 2020Dec 28, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
158,100$18.01$2.85M5,278,014Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
2,941,176$17.00$50.00M5,119,914Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
2,178,7382,178,738Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
65,047$20.00$1.30M5,538,219Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
SALE
318,0640Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
195,158$19.20$3.75M5,473,172Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
31,695$21.09$668.3K5,569,914Oct 14, 2020Oct 15, 2020View →
STTK
SHATTUCK LABS, INC.
PURCHASE
50,000$22.10$1.10M5,619,914Oct 14, 2020Oct 15, 2020View →
KYMR
KYMERA THERAPEUTICS, INC.
PURCHASE
1,630,6601,630,660Aug 25, 2020Aug 25, 2020View →
KYMR
KYMERA THERAPEUTICS, INC.
SALE
2,600,7400Aug 25, 2020Aug 25, 2020View →
ANNX
ANNEXON, INC.
SALE
14,062,7190Jul 28, 2020Jul 30, 2020View →
ANNX
ANNEXON, INC.
PURCHASE
1,596,2221,596,222Jul 28, 2020Jul 30, 2020View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
1,176,4700Jul 28, 2020Jul 30, 2020View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
1,176,4701,176,470Jul 28, 2020Jul 30, 2020View →
FATE
FATE THERAPEUTICS INC
PURCHASE
1,412,928$28.31$40.00M12,629,737Jun 11, 2020Jun 17, 2020View →
PLRX
PLIANT THERAPEUTICS, INC.
SALE
13,661,2020Jun 5, 2020Jun 9, 2020View →
PLRX
PLIANT THERAPEUTICS, INC.
PURCHASE
1,910,6571,910,657Jun 5, 2020Jun 9, 2020View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
16,00016,000May 1, 2020May 5, 2020View →
BEAM
BEAM THERAPEUTICS INC.
SALE
5,208,3330Feb 10, 2020Feb 11, 2020View →
BEAM
BEAM THERAPEUTICS INC.
PURCHASE
1,161,4581,161,458Feb 10, 2020Feb 11, 2020View →
Other insiders · FATE
Loading peer insiders…
About this filer
CIK 0001425738
ROLE
Director
PRIMARY
FATE
COMPANIES
12
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001425738DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback